title: [The treatment of hypertension patients with neurological disorders].
abstract: The authors describe the efficiency of complex treatment of patients suffering of hypertensive disease with phenomena of dyscirculatory encephalopathy. It is concluded that cavinton and pyracetam depending on the type of central hemodynamics and type of vegetative nervous activity proved effective.
authors.forename: I S
authors.initials: IS
authors.lastname: Zozulia
authors.forename: A A
authors.initials: AA
authors.lastname: Zozulia
authors.forename: V A
authors.initials: VA
authors.lastname: Shevchenko
authors.forename: E A
authors.initials: EA
authors.lastname: Buslo
authors.forename: A I
authors.initials: AI
authors.lastname: Galusha
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001581:Benzothiadiazines; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000209:etiology; D004232:Diuretics; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology; D010889:Piracetam / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014748:Vinca Alkaloids; C013983:vinpocetine; D010889:Piracetam